Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Inhibrx Biosciences, Inc.
The company shared information publicly (Regulation FD). An 8-K is the notice a US public company must file within four business days of a major event.
AI Executive Summary
AI-powered analysis of 8-K filing content
Inhibrx Biosciences updated and posted its corporate presentation on its investor relations website on September 28, 2026, for distribution to the investment community at conferences and meetings. This is a routine investor communication filing with no material business developments disclosed.
Key Takeaways
Company posted updated corporate presentation to investor relations website on September 28, 2026
Presentation is intended for use at investor conferences and meetings to communicate strategic progress
2 more takeaways
Filing Overview
What This Means
Inhibrx Biosciences, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.